Sanger Sequencing Market Overview, Key Trends, and Major Player Analysis

Sanger sequencing remains a pivotal technique in genetic research and clinical diagnostics, with its market poised to experience significant expansion over the coming years. As advancements continue and applications diversify, the global demand for this sequencing method is set to rise steadily, influenced by various factors shaping the industry landscape.

Projected Market Value and Growth Trajectory of the Sanger Sequencing Market
The sanger sequencing market is anticipated to grow rapidly, reaching a valuation of $7.13 billion by 2030. This corresponds to a robust compound annual growth rate (CAGR) of 16.7% during the forecast period. Several factors contribute to this growth, including the ongoing necessity for confirmatory sequencing alongside next-generation sequencing (NGS), increased use in personalized medicine, heightened demand for affordable targeted sequencing options, expanding clinical diagnostic applications in emerging regions, and strengthened collaborations between biotechnology companies and research institutions. Predominant trends expected to influence the market include sustained reliance on sanger sequencing to validate NGS findings, consistent demand for targeted gene sequencing in diagnostics, growing roles in biomarker and cancer research, greater outsourcing of sequencing tasks to specialized laboratories, and ongoing adoption in forensic analysis and reproductive health testing.

Download a free report of the sanger sequencing market report:
https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Prominent Companies Leading the Sanger Sequencing Market
Key players steering the sanger sequencing industry include well-established firms such as Hoffmann La Roche, Thermo Fisher Scientific Inc, Merck KGaA, Eurofins Scientific, Beckman Coulter, PerkinElmer Inc, LGC Limited, GenScript, Macrogen Inc, GENEWIZ Inc, Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty Ltd, SciGenom Labs Pvt Ltd, StarSEQ GmbH, GATC Biotech AG, Agilent Technologies, Azenta Life Sciences, CD Genomics, and Novogene Sanger Services.
In a notable move to strengthen market positioning, Qiagen, a Germany-based sample and assay technology provider, acquired Verogen in January 2023 for $150 million. This strategic acquisition enhances Qiagen's automation capabilities in sample extraction and library preparation while broadening both companies' reach within the forensic market. Verogen specializes in sanger sequencing services for human identification and forensic laboratories in the United States.

Emerging Developments and Expansion in Sanger Sequencing Services
The sanger sequencing market is witnessing strategic expansions, particularly in the genomic laboratory sector. Companies are increasingly investing in specialized genomic labs to offer faster and more efficient sequencing services. A case in point is Source Genomics, a UK-based genomic service provider, which in June 2023 announced the extension of its genomic laboratory facilities into northern parts of the UK. This expansion is set to enhance the capacity for Sanger sequencing, significantly improving turnaround times for data delivery. By broadening geographic access to these services, the company aims to ensure more equitable and timely genomic testing for research organizations across the nation.

View the full sanger sequencing market report:
https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Breakdown of Sanger Sequencing Market Segments Covered in the Report
This market report segments the sanger sequencing industry across several key dimensions:
1) By Sequencing Method: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing
2) By Laboratory Type: Wet Labs, Dry Labs
3) By Research Mode: In-House, Outsourced
4) By Application Area: Diagnostics, Biomarkers and Cancer Research, Reproductive Health, Personalized Medicine, Forensics, Other Applications
5) By End Users: Academic Institutions, Government Research Institutes, Pharmaceutical Companies, Biotechnology Firms, Hospitals, Clinics

Further subcategories include:
- Shotgun Sequencing: Whole Genome Shotgun Sequencing, Metagenomic Shotgun Sequencing
- Targeted Gene Sequencing: Amplicon Sequencing, Exome Sequencing
- Other Sequencing Methods: Nested PCR Sequencing, Capillary Electrophoresis-Based Sanger Sequencing

This comprehensive segmentation helps to provide a detailed understanding of the diverse uses and market dynamics of sanger sequencing technologies.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.